Schuth Alexander O.'s Form 4 filing
Denali Therapeutics Inc. (DNLI) · filed Nov 12, 2024
- Accession no.
- 0001714899-24-000218
- Filed
- Nov 12, 2024
- Trade date
- Nov 7, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $465.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuth Alexander O.CIK 0001724311 | Officer (COFO and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | Common Stock | MOption exerciseAcquired | +15,558 | $5.28 | +$82,146.24 | 193,624 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −12,333 | $29.68 | −$366,043.44 | 181,291 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −2,925 | $30.72 | −$89,856 | 178,366 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −300 | $31.29 | −$9,387 | 178,066 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | Common Stock | MOption exerciseDisposed | −15,558 | $0.00 | $0 | 53,379 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.